A series electrolytes for the operation of a LiFePO 4 cathode over a wide temperature range were designed by employing a lithium tetrafluoroborate (LiBF 4 )and lithium bis(oxalato)borate (LiBOB) salt mixture and an ester co-solvent methyl butanoate (MB) in a solvent mixture of 1:1:3 (v/v) propylene carbonate (PC) /ethylene carbonate (EC) /ethylmethyl carbonate (EMC). And prepared electrolytes were compared to the reference mixture EC/PC/3EMC (LiPF 6 , 1 M). Cells temperature performance was systematically investigated by ionic conductivity test and various electrochemical tests, such as cyclic voltammetry (CV), electrochemical impedance spectroscopy (EIS), and charge-discharge test. It was found that the temperature performance of Li/LiFePO 4 cells could be optimized by using a LiBF 4 -LiBOB salt mixture and MB co-solvent. At −40°C, for example, a Li/LiFePO 4 cell using 1 M LiBF 4 :LiBOB(8:2) PC:EC:EMC:MB(1:1:1:2 v/v) electrolyte could provide up to 60% of capacity, while still had a voltage platform of 3 V. And it still retained 80% of capacity after 100 cycles at 65°C, 1 C.
No takes yet. Share an insight, caveat, or question.
Lai et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: